Founded In 1998, Mercury Healthcare Pvt. Ltd. is a leading Indian Pharmaceuticals Company specializing in Manufacturing and Exporting a wide range of high-quality, affordable medicines globally. Our FDA-Approved Manufacturing facilities ensure compliance with stringent Regulatory Standards, supported by approvals from NAFDAC- Nigeria, FDA- Ghana, MOH- Cambodia, PPB- Kenya, DPML- Ivory Coast and FMHACA- Ethiopia. We excel in producing cost-effective Active Pharmaceutical Ingredients (APIs), enhancing accessibility to Healthcare across diverse markets.
Kantilal Shah, Chairman of MERCURY HEALTHCARE, is a visionary leader committed to advancing global healthcare standards. He prioritizes fost…
Harish Shah, Director of Mercury Healthcare Pvt. Ltd., champions global strategy, customer interaction, and international business developme…
These are entries in government registers. BharatSeal has not checked them separately.
Record completeness: 5 of 7 records on file
Not on record: GST registration, Income-tax PAN
Export details the company has shared.
7 facts · 0 checked · 5 on record or declared · 2 unknown
Checks confirm records. They do not prove quality or delivery.
Pharmaceutical, Cosmetic, Food, Beverages
Panvel, MH, India
No. Mercury Pharmachem Industries Pvt Ltd has not claimed its BharatSeal profile. Registry records on this page are on record in government registers; BharatSeal has not checked them separately.
Mercury Pharmachem Industries Pvt Ltd was incorporated in 1983 per Ministry of Corporate Affairs records under CIN U24239MH1983PTC030037. The company has been operating for 43 years, with the registration auditable on mca.gov.in.
Mercury Pharmachem Industries Pvt Ltd's current directors include Harish Shah. Director records are sourced from the MCA21 corporate registry and reflect the latest filing with the Ministry of Corporate Affairs.
Yes — exports to Nigeria, Ghana, Myanmar, Nicaragua, Cambodia, Ethiopia, Kenya, Ivory Coast.
Send an enquiry through BharatSeal. Every enquiry is logged so you have a record of the conversation.